tizanidine hydrochloride
- Product NDC
- 63629-6537
- 11-digit product format
- 636296537
- Labeler code
- 63629
- Product ID
- 63629-6537_3ff8cd7c-7327-4b66-a9c0-38bf47e1a6e4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tizanidine hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA076280
- Marketing category
- ANDA
- Marketing start
- 2002-06-27
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63629-6537-1 | 63629653701 | 60 TABLET in 1 BOTTLE (63629-6537-1) | 60 tablet | 2015-07-27 | 0000-00-00 | No | No | Current |
| 63629-6537-2 | 63629653702 | 30 TABLET in 1 BOTTLE (63629-6537-2) | 30 tablet | 2015-07-27 | 0000-00-00 | No | No | Current |
| 63629-6537-3 | 63629653703 | 90 TABLET in 1 BOTTLE (63629-6537-3) | 90 tablet | 2015-07-27 | 0000-00-00 | No | No | Current |